Amgen Inc. or Perrigo Company plc: Who Leads in Yearly Revenue?

Amgen Inc. vs. Perrigo Company plc: A Revenue Showdown

In the competitive landscape of the pharmaceutical industry, revenue growth is a key indicator of success. From 2014 to 2023, Amgen Inc. has consistently outperformed Perrigo Company plc in terms of annual revenue. Amgen's revenue surged by approximately 40% over this period, peaking at $28.19 billion in 2023. In contrast, Perrigo's revenue saw a modest increase of around 15%, reaching $4.66 billion in the same year.

A Decade of Growth

Amgen's strategic investments and innovative product lines have fueled its impressive growth, while Perrigo has maintained steady progress despite market challenges. The data highlights Amgen's dominance, with its revenue consistently being over four times that of Perrigo's. This trend underscores Amgen's robust market position and its ability to adapt to changing industry dynamics. As the pharmaceutical sector continues to evolve, these companies' financial trajectories offer valuable insights into their strategic priorities and market resilience.